why choose us

First received: March 13, 2023

Clinical Trial: A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Warm Autoimmune Hemolytic Anemia

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With An Open Label Safety and Dose Confirmation Run-In Period, To Evaluate the Efficacy and Safety of Obexelimab in Patients

Brief Summary: This study aims to examine the efficacy and safety of obexelimab in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).

Read more